B. Iacopetta

N. Warrington, L. Palmer, J. Golledge, 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Internalization pathway of C3b receptors in human neutrophils and its transmodulation by chemoattractant receptors stimulation.

T. Pozzan, M. Kazatchkine, B. Iacopetta, 1991, Cell regulation.

Are some breast cancers sexually transmitted?

B. Iacopetta, J. Lawson, N. Whitaker, 2006, British Journal of Cancer.

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome

M. Salto‐Tellez, N. Zeps, B. Iacopetta, 2009, British Journal of Cancer.

Microsatellite instability in colorectal cancer: prognostic, predictive or both?

B. Iacopetta, H. Elsaleh, M. van Rijnsoever, 2002, The American journal of pathology.

A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.

B. Iacopetta, R. Soong, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

The p53 tumor-suppressor gene is overexpressed but not mutated in human atherosclerotic tissue.

B. Iacopetta, A. House, S. Wysocki, 1995, International journal of oncology.

Tumour site, sex, and survival in colorectal cancer

B. Iacopetta, H. Elsaleh, 2000, The Lancet.

FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancer

B. Iacopetta, C. Platell, C. Stewart, 2012, Cancer Immunology, Immunotherapy.

Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.

C. Tournigand, M. Loh, P. Senet, 2014, Gastroenterology.

A state-wide population-based program for detection of Lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours

B. Iacopetta, F. Grieu, J. Goldblatt, 2012, Hereditary Cancer in Clinical Practice.

POPULATION‐BASED SCREENING FOR HEREDITARY NON‐POLYPOSIS COLORECTAL CANCER (LYNCH SYNDROME): THE WESTERN AUSTRALIAN APPROACH

B. Iacopetta, C. Platell, 2007, ANZ journal of surgery.

Feasibility of low-throughput next generation sequencing for germline DNA screening.

Y. Teo, M. Loh, B. Iacopetta, 2014, Clinical chemistry.

Integrating next‐generation sequencing into the diagnostic testing of inherited cancer predisposition

D. Cooper, C. Ku, B. Iacopetta, 2013, Clinical genetics.

Exome versus transcriptome sequencing in identifying coding region variants

Y. Pawitan, D. Cooper, C. Ku, 2012, Expert review of molecular diagnostics.

CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.

B. Iacopetta, H. Elsaleh, D. Joseph, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset.

E. Berns, B. Iacopetta, B. Powell, 2003, The Journal of clinical endocrinology and metabolism.

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

이석호, 황수찬, T. Walsh, 2001, British Journal of Cancer.

Heme inhibits transferrin endocytosis in immature erythroid cells.

B. Iacopetta, E. Morgan, Barry Iacopetta, 1984, Biochimica et biophysica acta.

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.

L. Saal, C. Sotiriou, S. Loi, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PIK3CA mutations in breast cancer are associated with poor outcome

B. Iacopetta, F. Grieu, Shaoying Li, 2006, Breast Cancer Research and Treatment.

Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X

Y. Pawitan, D. Cooper, C. Ku, 2012, Modern Pathology.

DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach

M. Salto‐Tellez, M. Loh, B. Iacopetta, 2014, BMC Gastroenterology.

Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples

S. Fox, S. Hendry, B. Iacopetta, 2018, Oncotarget.

Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability.

G. Thomas, A. Duval, R. Hamelin, 1999, Cancer research.

Expression of PD-L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion

B. Iacopetta, T. Miller, C. Platell, 2018, Oncology letters.

The topography of DNA methylation in the non‐neoplastic colonic mucosa surrounding colorectal cancers

M. Salto‐Tellez, M. Loh, B. Iacopetta, 2014, Molecular carcinogenesis.

A population-based study of age-related variation in clinicopathological features, molecular. Markers and outcome from colorectal cancer.

B. Iacopetta, C. Platell, M. Morris, 2007, Anticancer research.

The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.

D. Kerr, T. Soussi, B. Iacopetta, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers.

G. Thomas, A. Duval, R. Hamelin, 2001, Human molecular genetics.

Mutation of the transforming growth factor‐β type II receptor gene in right‐sided colorectal cancer: relationship to clinicopathological features and genetic alterations

R. Hamelin, B. Iacopetta, R. Soong, 1998, The Journal of pathology.

Advances in Next Generation Sequencing Technologies and Cancer Epigenomics

C. Ku, B. Iacopetta, R. Soong, 2012 .

DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer

G. Watanabe, K. Kawakami, B. Iacopetta, 2006, British Journal of Cancer.

Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.

B. Iacopetta, M. Millward, Tindaro M Giardina, 2018, Pathology.

Next-Generation Sequencing in Cancer Epigenomics and Potential Clinical Applications

C. Ku, B. Iacopetta, D. Roukos, 2013 .

Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region

B. Iacopetta, M. Millward, F. Grieu, 2012, Pathology.

Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients.

N. Zeps, B. Iacopetta, D. Joseph, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A role for the cytoplasmic domain in transferrin receptor sorting and coated pit formation during endocytosis

L. Kühn, B. Iacopetta, S. Rothenberger, 1988, Cell.

Role of intracellular calcium and protein kinase C in the endocytosis of transferrin and insulin by HL60 cells

L. Orci, T. Pozzan, B. Iacopetta, 1986, The Journal of cell biology.

Sarcomatoid Renal Cell Carcinoma of Papillary Origin

J. McNeal, R. Cohen, B. Iacopetta, 2000 .

The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes.

B. Iacopetta, E. Morgan, 1983, The Journal of biological chemistry.

CD133 expression predicts for non-response to chemotherapy in colorectal cancer

M. Salto‐Tellez, B. Iacopetta, R. Soong, 2010, Modern Pathology.

Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands

B. Iacopetta, H. Elsaleh, D. Joseph, 2002, Gut.

Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis

B. Iacopetta, R. Soong, B. Tai, 2018, Oncotarget.

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.

B. Iacopetta, P. Robbins, B. Dix, 1994, British Journal of Cancer.

Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency.

A. Duval, R. Hamelin, B. Iacopetta, 2002, Cancer research.

Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis

B. Iacopetta, R. Soong, R. Soo, 2017, Oncotarget.

Phosphatidylinositol‐3‐kinase pathway aberrations in gastric and colorectal cancer: Meta‐analysis, co‐occurrence and ethnic variation

M. Loh, B. Iacopetta, R. Soong, 2014, International journal of cancer.

BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status

K. Kawakami, B. Iacopetta, A. Ruszkiewicz, 2006, Molecular Cancer.

3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.

D. Goldstein, B. Iacopetta, A. Kneebone, 2008, International journal of radiation oncology, biology, physics.

MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer.

M. Salto‐Tellez, M. Loh, B. Iacopetta, 2010, European journal of cancer.

Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

N. Zeps, B. Iacopetta, D. Joseph, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Villin expression is frequently lost in poorly differentiated colon cancer.

L. Aaltonen, D. Arango, J. Mariadason, 2012, The American journal of pathology.

Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancer

L. Wong, M. Salto‐Tellez, M. Loh, 2011, Cancer biology & therapy.

Epstein-Barr Virus, Human Papillomavirus and Mouse Mammary Tumour Virus as Multiple Viruses in Breast Cancer

B. Iacopetta, W. Delprado, J. Lawson, 2012, PloS one.

Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR.

A. Duval, R. Hamelin, B. Iacopetta, 2002, Gastroenterology.

Detection of surface-bound ligands by freeze-fracture autoradiography

L. Orci, B. Iacopetta, J. Carpentier, 1985, The Journal of cell biology.

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?

M. Loh, N. Zeps, B. Iacopetta, 2012, The Pharmacogenomics Journal.

Diacylglycerol Modulation of Insulin Receptor From Cultured Human Mononuclear Cells: Effects on Binding and Internalization

G. Grunberger, B. Iacopetta, J. Carpentier, 1986, Diabetes.

Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.

S. Culine, B. Iacopetta, C. Theillet, 2000, Cancer research.

A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting.

M. Salto‐Tellez, S. Fox, R. Scott, 2009, The Journal of molecular diagnostics : JMD.

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer

S. Clarke, D. Goldstein, B. Iacopetta, 2009, British Journal of Cancer.

Mutant K-ras2 in serum

A. Norman, B. Iacopetta, D. Cunningham, 2003, Gut.

Prognostic Significance of Microsatellite Instability and Ki-ras Mutation Type in Stage II Colorectal Cancer

B. Iacopetta, H. Elsaleh, D. Joseph, 2003, Oncology.

Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases

B. Iacopetta, M. Platten, F. Grieu, 2005, Pathology.

The −174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype

B. Iacopetta, D. Joseph, F. Grieu, 2004, British Journal of Cancer.

Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.

B. Iacopetta, B. Powell, R. Soong, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas.

B. Iacopetta, R. Soong, P. Robbins, 1996, Human pathology.

Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race.

Chun Meng Song, M. Loh, K. Chia, 2009, European Journal of Cancer.

p53 and disease: when the guardian angel fails

B. Iacopetta, J. Royds, B Iacopetta, 2006, Cell Death and Differentiation.

BRAF mutation and gene methylation frequencies of colorectal tumours with microsatellite instability increase markedly with patient age

K. Kawakami, B. Iacopetta, F. Grieu, 2005, Gut.

Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.

B. Iacopetta, D. Joseph, F. Grieu, 2003, Anticancer research.

FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor

Alison White, B. Iacopetta, M. Millward, 2015, Pathology.

A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma

S. Fox, H. Do, A. Dobrovic, 2013, Scientific Reports.

Significance of pS2 mRNA in Cancer

B. Iacopetta, S. Wysocki, 1994 .

Prognostic significance of pS2 mRNA in breast cancer.

B. Iacopetta, S. Wysocki, D. Ingram, 1994, European journal of cancer.

Methylation levels of LINE‐1 repeats and CpG island loci are inversely related in normal colonic mucosa

K. Kawakami, B. Iacopetta, T. Minamoto, 2007, Cancer science.

Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.

B. Iacopetta, Shaoying Li, M. Rong, 2006, Oncology reports.

The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase.

G. Watanabe, K. Kawakami, B. Iacopetta, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Aberrant DNA methylation: have we entered the era of more than one type of colorectal cancer?

B. Iacopetta, 2003, The American journal of pathology.

Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype.

J. Beilby, B. Iacopetta, B. Powell, 2004, Anticancer research.

The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.

B. Iacopetta, M. Bulsara, T. Miller, 2017, Pathology.

Detection of BRAF V600E mutation by pyrosequencing

Wei Qi Li, Manuel Salto-Tellez, Richie Soong, 2008, Pathology.

Conservation of mononucleotide repeats within 3′ and 5′ untranslated regions and their instability in MSI-H colorectal cancer

A. Duval, R. Hamelin, B. Iacopetta, 2001, Oncogene.

Reply to C. Badoual et al

B. Iacopetta, C. Platell, P. Salama, 2009 .

Identification of human papillomavirus DNA gene sequences in human breast cancer

J S Lawson, B. Iacopetta, J. Lawson, 2005, British Journal of Cancer.

Microsatellite instability in colorectal cancer

B. Iacopetta, F. Grieu, B. Amanuel, 2010, Asia-Pacific journal of clinical oncology.

Dietary and Supplemental Folate and the Risk of Left- and Right-Sided Colorectal Cancer

B. Iacopetta, L. Fritschi, J. Heyworth, 2012, Nutrition and cancer.

Nested PCR-SSCP assay for the detection of p53 mutations in paraffin wax embedded bone tumours: improvement of sensitivity and fidelity

B. Iacopetta, J. Papadimitriou, M. Zheng, 1996, Clinical molecular pathology.

Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case-control study in Western Australia.

B. Iacopetta, S. McNaughton, L. Fritschi, 2011, Journal of the American Dietetic Association.

Fruit and Vegetable Consumption and the Risk of Proximal Colon , Distal Colon , and Rectal Cancers in a Case-Control Study in Western Australia NDER EMBARGO UNTIL SEPTEMBER

B. Iacopetta, S. McNaughton, J. Heyworth, 2011 .

Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism.

B. Iacopetta, H. Elsaleh, D. Joseph, 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

D. Kerr, R. Lothe, V. Moreno, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability

J. Beilby, B. Iacopetta, B. Shannon, 2002, Gut.

APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer

G. Watanabe, K. Kawakami, B. Iacopetta, 2006, International journal of cancer.

Methyl-group metabolism and the response of colorectal cancer to 5-fluorouracil.

B. Iacopetta, 2006, Critical reviews in oncogenesis.

Hypermethylation of the Myf-3 gene in human colorectal cancer.

B. Iacopetta, A. House, D. Spagnolo, 1997, Anticancer research.

Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.

B. Iacopetta, J. Goldblatt, L. Schofield, 2011, Rural and remote health.

A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours

B. Iacopetta, F. Grieu, J. Goldblatt, 2012, Familial Cancer.

Waiver of individual patient consent in research: when do potential benefits to the community outweigh private rights?

Nikolajs Zeps, Jack Goldblatt, Lyn Schofield, 2007, The Medical journal of Australia.

HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer

H. Blanché, C. Lepage, A. Duval, 2016, Journal of Medical Genetics.

Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals

B. Iacopetta, C. Platell, M. Morris, 2007, The Medical journal of Australia.

Predictive values of sex and tumour site for survival benefit from 5FU in colorectal cancer

B. Iacopetta, 2002, British Journal of Cancer.

Extent of Nodal Involvement in Stage III Colorectal Carcinoma

B. Iacopetta, H. Elsaleh, G. Cserni, 2002, Diseases of the colon and rectum.

Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability

R. Lothe, G. Thomas, A. Duval, 1999, Oncogene.

Rapid and nonisotopic SSCP‐based analysis of the BAT‐26 mononucleotide repeat for identification of the replication error phenotype in human cancers

R. Hamelin, B. Iacopetta, 1998, Human mutation.

Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil Chemotherapy

B. Iacopetta, C. Platell, M. Morris, 2008, Clinical Cancer Research.

Prognostic and predictive significance of 5-fluorouracil metabolic enzymes in colorectal cancer.

M. Salto‐Tellez, R. Diasio, N. Zeps, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitive and cost-effective detection of epidermal growth factor receptor mutations in small biopsies by denaturing high performance liquid chromatography.

M. Salto‐Tellez, B. Goh, K. Kawakami, 2005 .

Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival

B. Iacopetta, M. Morris, B. de Boer, 2007, Histopathology.

Detection of epidermal growth factor receptor variations by partially denaturing HPLC.

M. Salto‐Tellez, B. Goh, K. Kawakami, 2007, Clinical chemistry.

Selected dietary micronutrients and the risk of right- and left-sided colorectal cancers: a case-control study in Western Australia.

B. Iacopetta, S. McNaughton, L. Fritschi, 2011, Annals of epidemiology.

Expression of sFRP-4 and β-catenin in human colorectal carcinoma

N. Zeps, B. Iacopetta, D. Joseph, 2006 .

Reply: Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil

B. Iacopetta, H. Elsaleh, 2002, British Journal of Cancer.

Objective analysis of cancer stem cell marker expression using immunohistochemistry.

B. Iacopetta, M. Bulsara, T. Miller, 2017, Pathology.

Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype

B. Iacopetta, F. Grieu, W. Li, 2004, Breast Cancer Research and Treatment.

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

E. Berns, B. Iacopetta, B. Powell, 2001, Breast Cancer Research and Treatment.

Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting

B. Iacopetta, M. Millward, K. McCaul, 2007, International Journal of Colorectal Disease.

p53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma.

B. Iacopetta, B. Powell, R. Soong, 1999, International Journal of Oncology.

Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm

N. Warrington, J. Golledge, B. Iacopetta, 2008, The British journal of surgery.

Polymorphisms of the interleukin-6 gene promoter and abdominal aortic aneurysm.

N. Warrington, L. Palmer, P. Norman, 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

PCR versus immunohistochemistry for microsatellite instability.

R. Broaddus, B. Iacopetta, W. Samowitz, 2008, The Journal of molecular diagnostics : JMD.

P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas.

B. Iacopetta, H. Elsaleh, D. Joseph, 1999, International journal of oncology.

Detection of p53 gene mutation by rapid PCR‐SSCP and its association with poor survival in breast cancer

B. Iacopetta, R. Soong, P. Robbins, 1997, International journal of cancer.

Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF‐β type II receptor, IGFII receptor, and BAX genes

R. Hamelin, B. Iacopetta, R. Soong, 1999, The Journal of pathology.

Hypermethylation of the Myf‐3 gene in colorectal cancers: Associations with pathological features and with microsatellite instability

B. Iacopetta, P. Kay, B. Shannon, 1999, International journal of cancer.

Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features

M. Loh, B. Iacopetta, R. Soong, 2010, BMC Cancer.